Skip to main content

Table 1 Characteristics of ovarian cancer patients and control groups: benign ovarian tumor and healthy subjects

From: The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors

Study group

 

Number of patients

Epithelial ovarian cancer patients

 

100 (100%)

• median age (range)

 

59 (46–87)

- sub-type serous epithelial

 

54 (54%)

• median age (range)

 

59 (46–81)

- sub-type endometrioid epithelial

 

46 (46%)

• median age (range)

 

59 (49–87)

Tumor stage

IA-T1aN0M0

5 (5%)

IB-T1bN0M0

7 (7%)

IC-T1cN0M0

13 (13%)

IIA-T2aN0M0

8 (8%)

IIB-T2bN0M0

9 (9%)

IIC-T2cN0M0

8 (8%)

IIIA-T3aN0M0

9 (9%)

IIIB-T3bN0M0

9 (9%)

IIIC-T3cN0M0

7 (7%)

IV(metastases)

25 (25%)

Menopausal status:

  

- postmenopausal

 

100 (100%)

Benign ovarian tumor patients

 

80 (100%)

- type cystis serous

 

40 (50%)

- type cystis endometriosis

 

40 (50%)

Median age (range)

 

54 (48–68)

Menopausal status:

  

- postmenopausal

 

80 (100%)

Healthy subjects

 

50 (100%)

Median age (range)

 

55 (47–64)

Menopausal status:

  

- postmenopausal

 

50 (100%)